Sustained HIV RNA suppression after switching from enfuvirtide to etravirine in the early access programme [letter]

M Loutfy, E Ribera, E Florence, S De Wit, A Castagna, R Ryan, A Hill, H Vanaken, Y van Delft, S Marks

    Research output: Contribution to journalLetter

    Original languageEnglish
    JournalJournal of Antimicrobial Chemotherapy
    Volume64
    Issue number6
    Pages (from-to)1341-1344
    Number of pages4
    ISSN0305-7453
    Publication statusPublished - 2009

    Keywords

    • B780-tropical-medicine
    • Viral diseases
    • HIV
    • Drug therapy
    • Reverse transcriptase inhibitors
    • Non-nucleoside
    • Fusion inhibitors
    • Enfuvirtide
    • Etravirine
    • CD4 lymphocyte count
    • RNA suppression
    • Tolerability
    • Convenience
    • Clinical trials

    Cite this